Clinical trials
Withdrawn Uterine Cervical Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 58 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| University of California, San Diego | 3 |
| Agenus Inc. | 2 |
| Case Comprehensive Cancer Center | 2 |
| AIDS Malignancy Consortium | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Accelerated Community Oncology Research Network | 1 |
| Australia New Zealand Gynaecological Oncology Group | 1 |
| British Columbia Cancer Agency | 1 |
| Centre Leon Berard | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 58 |
| Endometrial Neoplasms | 8 |
| Ovarian Neoplasms | 8 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Uterine Cervical Dysplasia | 5 |
| Breast Neoplasms | 4 |
| Carcinoma, Renal Cell | 4 |
| Colorectal Neoplasms | 4 |
| Esophageal Neoplasms | 4 |
| Fallopian Tube Neoplasms | 4 |
Trials
Showing 51 to 58 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.